RhumbLine Advisers’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-140,869
| Closed | -$7.19M | – | 4171 |
|
|
2024
Q4 | $7.19M | Sell |
140,869
-4,356
| -3% | -$222K | 0.01% | 1227 |
|
|
2024
Q3 | $5.99M | Sell |
145,225
-4,858
| -3% | -$200K | 0.01% | 1332 |
|
|
2024
Q2 | $7.23M | Sell |
150,083
-1,038
| -0.7% | -$50K | 0.01% | 1188 |
|
|
2024
Q1 | $7.25M | Sell |
151,121
-11,741
| -7% | -$563K | 0.01% | 1215 |
|
|
2023
Q4 | $10.6M | Sell |
162,862
-1,734
| -1% | -$113K | 0.01% | 1029 |
|
|
2023
Q3 | $10.8M | Buy |
164,596
+2,344
| +1% | +$153K | 0.01% | 951 |
|
|
2023
Q2 | $9.43M | Buy |
162,252
+9,327
| +6% | +$542K | 0.01% | 1038 |
|
|
2023
Q1 | $9.44M | Sell |
152,925
-521
| -0.3% | -$32.2K | 0.01% | 987 |
|
|
2022
Q4 | $9.75M | Buy |
153,446
+4,979
| +3% | +$316K | 0.01% | 954 |
|
|
2022
Q3 | $10.8M | Buy |
148,467
+29,865
| +25% | +$2.17M | 0.02% | 853 |
|
|
2022
Q2 | $8.06M | Buy |
118,602
+82,605
| +229% | +$5.62M | 0.01% | 1005 |
|
|
2022
Q1 | $3.26M | Buy |
35,997
+1,005
| +3% | +$91.1K | ﹤0.01% | 1563 |
|
|
2021
Q4 | $3.19M | Sell |
34,992
-430
| -1% | -$39.3K | ﹤0.01% | 1617 |
|
|
2021
Q3 | $2.87M | Buy |
35,422
+1,317
| +4% | +$107K | ﹤0.01% | 1685 |
|
|
2021
Q2 | $3.18M | Buy |
34,105
+15,246
| +81% | +$1.42M | ﹤0.01% | 1693 |
|
|
2021
Q1 | $2.02M | Buy |
18,859
+8,613
| +84% | +$922K | ﹤0.01% | 1908 |
|
|
2020
Q4 | $894K | Buy |
10,246
+2,214
| +28% | +$193K | ﹤0.01% | 2188 |
|
|
2020
Q3 | $554K | Buy |
+8,032
| New | +$554K | ﹤0.01% | 2242 |
|